Latest News

CHAIN Wins Business Interaction Voucher with University of Nottingham

CHAIN Biotechnology has been awarded a £5,000 Business Interaction Voucher in partnership with the University of Nottingham’s Synthetic Biology Research Centre (SBRC). The Voucher, awarded by the Plants to Products (P2P) Network in Biotechnology and Bioenergy and funded by the BBSRC, will fund a project to develop a multi-parallel bioreactor screening method for anaerobic bacteria.

Important Anaerobes

Anaerobes like Clostridium are capable of producing a variety of useful chemicals including the biofuel butanol and the solvent acetone. Research into developing novel strains of Clostridia for productive use has been hampered by a lack of tools and methods for cultivation and screening. CHAIN aims to use recent fermentation advances to develop a micro-cultivation methods for the screening different Clostridia strains.

CHAIN is partnering with Clostridia researcher Dr Klaus Winzer, Associate Professor at the University’s £14.3m SBRC under Professor Nigel Minton. Through this project, CHAIN aims to develop new academic ties in the field of Clostridia research.

Accelerating Strain Development

CHAIN’s CEO, Dr Edward Green, said “We are happy to start a new project with this Voucher from P2P. This enables us to tap into academic expertise at the SBRC and access specialist equipment to accelerate strain development.”

This Voucher from P2P marks CHAIN’s first grant award from the BBSRC-funded Networks in Biotechnology and Bioenergy. CHAIN will also be represented by Research Manager Dr Dana Heldt at the P2P showcase at the Pendulum Hotel, Manchester, on November 10th and 11th.

See a full list of the BIV winners here.

Related News

CHAIN Appoints New Board Members

CHAIN welcomes to its Board of Directors the recent appointment of Dr Mike McDonald...

CHAIN Finalists in Biotechnology Awards

CHAIN Biotechnology is proud to announce that it is a finalist in two competitions...

CHAIN Celebrates Successful ‘Chiral Chemical Synthesis in Clostridia’ Study

LONDON, UK, 10 AUGUST 2016 -- CHAIN Biotechnology Ltd has successfully completed a 12-month...

omega 3 nutritional supplements
CHAIN Obtains Grant Funding For Collaborative Projects

June 11, 2016 – London, UK. CHAIN Biotechnology Ltd has won grant funding for...

CHAIN new employees clostridium modular vectors omega 3
CHAIN Welcomes New Starters

CHAIN has hired two new world class scientific team members to expand its role...

CHAIN Secures Seed Funding and Appoints New Board Members

London, UK, 23 December, 2015 CHAIN has successfully completed its first round of seed funding...

CHAIN HPLC Analysis of Chiral Chemicals Innovate UK feasibility study for Collaboration Nation: synthetic biology and strain development of anaerobic bacteria
CHAIN Celebrates Feasibility Study Success at Collaboration Nation

CHAIN Biotech has successfully completed a feasibility study into altering bacterial metabolism to produce...

CHAIN launches a new grant funded research project

CHAIN has been awarded £180K from InnovateUK for a project focused on the production...

CHAIN wins award and launches new website

Award winning CHAIN Biotech launches its new website, funded by a prize voucher from...

CHAIN joins University of Nottingham Synthetic Biology Research Centre

CHAIN Biotechnology Ltd is proud to announce a new collaboration with Professor Nigel Minton’s...

CHAIN hires Research Manager

CHAIN Biotechnology Ltd welcomes Dr Dana Heldt. Dana is an experienced strain development scientist...